secwatch.observer — SEC 8-K summary
======================================

Issuer:     DYNAVAX TECHNOLOGIES CORP (—)
CIK:        0001029142
Form:       8-K
Filed at:   2024-08-02T23:59:59+00:00
Accession:  0000950170-24-089940
Event type: leadership
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Dynavax reappoints Kelly MacDonald as CFO upon return from maternity leave
--------------------------------------------------------------------------

- Effective August 1, 2024, Board reappointed Kelly MacDonald as CFO (principal financial officer) after maternity leave.
- CEO Ryan Spencer had served as Interim CFO during MacDonald's leave; he now returns solely to CEO role.
- No change in MacDonald's compensation as a result of the reappointment.
- MacDonald's biographical information is referenced from the April 11, 2024 proxy statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1029142/000095017024089940/0000950170-24-089940-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1029142/000095017024089940/dvax-20240801.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-089940

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer